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2 
Summary 
 
Background 
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease associated with reduced life 
expectancy. It is heritable and an extensive repertoire of genetic variants have been identified. The gut 
microbiota may represent an environmental risk factor for RA. Indeed, Prevotella copri is a candidate keystone 
species, but whether it lies on the causal pathway for disease or is simply a bystander reflecting host-genetic 
predisposition to RA, remains to be determined. The study of disease-microbiota associations may be 
confounded by the presence of the disease of interest or by its treatment. To circumvent this issue, we assessed 
whether known RA risk alleles were associated with the gut microbiota, in a large population who do not have 
RA. 
 
Methods 
Blood and stool acquired from volunteers from TwinsUK were used for genotyping and assessment of the gut 
microbiota, respectively. A weighted polygenic risk score (PRS) for RA was calculated in 1650 unaffected 
twins from the TwinsUK cohort, based on 233 GWAS-identified published RA associated single nucleotide 
polymorphisms. Amplicon sequence variants were generated from 16S rRNA sequencing of stool samples and 
assessed for association with RA PRS. Confirmation of findings was performed using an independent sample 
comprised of first-degree relatives of RA patients from the SCREEN-RA cohort (n=133). 
 
Findings 
We found that Prevotella spp was positively associated with RA PRS in TwinsUK participants (q <1e-7). This 
finding was validated in SCREEN-RA participants carrying the shared epitope risk alleles (q = 1·12e-3). An 
association of Prevotella spp. with pre-clinical RA phases was also demonstrated (q = 0·021). 
 
Interpretation 
Prevotella in the gut microbiota is associated with RA genotype in the absence of RA, as well as in subjects at 
high risk of developing RA. This work suggests that host genotype is associated with microbiota profile prior to 
disease onset. 
 
Funding 
Versus Arthritis 
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Research in context  
 
Evidence before this study 
A literature search was conducted using Google Scholar. Search terms were broad and included “rheumatoid 
arthritis microbiome”; “rheumatoid arthritis Prevotella”; “microbiome heritability”; “microbiome, genetics 
rheumatoid arthritis”; “rheumatoid arthritis genetic aetiology”. The reference list of identified papers were 
further used to identify relevant literature. Prevotella copri has been shown to be increased within the gut 
microbiota of rheumatoid arthritis (RA) patients, predominantly those with early disease, before treatment is 
initiated. Prevotellaceae (family) has also been demonstrated to be increased in pre-clinical RA cases compared 
to controls. Prevotella copri is posited to be an inflammatory driver, contributing to RA pathology by promoting 
a pro-inflammatory cytokine milieu.  
 
Added value of this study 
This study is the first to demonstrate that, in a large human cohort, carrying genetic risk factors for RA is 
associated with a higher abundance of Prevotella spp. in the absence of any form of RA.  
 
Implications of all the available evidence 
Within the gut microbiota, Prevotella spp. including, but not limited to Prevotella copri are of interest in the 
pathogenesis of rheuamatoid arthritis. This work suggests that any potential causal role of Prevotella spp. occurs 
very early in disease development.   
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Introduction 
 
Rheumatoid arthritis (RA) is a debilitating chronic autoimmune condition, associated with reduced life 
expectancy. There is a substantial genetic component to RA aetiology, with heritability estimated at 65%.1 
Known environmental risk factors include periodontal disease, tobacco smoking and diet, and appear to trigger 
disease onset in genetically susceptible individuals.2 More recently proposed RA risk factors include the 
mucosal commensal microbiota. There is extensive cross-talk between the microbiota and the host, starting early 
in life with the development of the normal immune system; the microbiota may be implicated in the 
development of RA.   
 
The gut lumen holds the vast majority of the commensal microbiota, and has intimate proximity to both the 
immune system via the gut associated lymphoid tissue, and the systemic circulation. A key gut microbiota 
taxonomic association demonstrated in RA patients, which presents early in the course of RA is a relative 
increase in the abundance of Prevotella spp,3 and particularly Prevotella copri (P.copri).4,5 Further evidence 
supporting the pathophysiological relevance of P.copri in RA is provided by a positive correlation with clinical 
parameters in RA patients.5 In addition to promoting disease activity, the gut microbiota may also influence 
patient response to treatment.5,6 The gut microbiota therefore represents a potential therapeutic target in RA, 
both for modulation of disease and for improving response to established therapeutics. 
 
Identifying how RA genetic and environmental risk factors interact with one another may shed light on the 
underlying biology of disease. The influence of host genetic factors on the microbiota in RA remains relatively 
unexplored. An important influence is highly plausible: host genetics shape the biochemical and immune 
environment in which the microbiota reside, and furthermore the cumulative influence of the genetic risk loci in 
RA is predominantly mediated by immune pathways.2 Whilst there are a number of factors which influence 
microbiota composition, host genetic factors account for a considerable proportion of variance, with some taxa 
being 40% heritable.7  
 
The purpose of this study was to investigate the influence of RA genetic risk factors on the gut microbiota. The 
use of a population sample TwinsUK,8 whilst excluding RA affected participants allows for isolation of RA 
genetic factors and circumvents the important issues of confounding by RA disease and its treatment - thereby 
achieving a human model of the genetic association with the microbiota in RA. An RA polygenic risk score in 
unaffected TwinsUK participants was calculated and association determined with composition of the gut 
microbiota. Validation studies confirmed and extended our findings by examining the gut microbiota 
composition in first-degree relatives of RA patients (SCREEN-RA cohort) in relation to shared epitope 
positivity, and a pre-disease state as defined by clinical RA parameters.9 
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Methods 
 
Study Overview 
This study was conducted in the UK and Switwerland, and comprised participants of the TwinsUK (primary) 
and SCREEN-RA (validation) cohorts. We investigated whether genetic risk for RA was associated with the gut 
microbiota. In order to isolate genetic influence on disease from the pathophysiology and treatment influence of 
established disease, TwinsUK participants with RA and their co-twin were excluded from the study. 1650 
eligible TwinsUK participants contributed blood and stool, which were used to determine genotype and gut 
microbiota composition, respectively. Genetic risk for RA in TwinsUK participants was captured using 
polygenic risk scoring. An RA polygenic risk score (PRS) was generated and validated using logistic regression 
against RA diagnosis in UK Biobank (UKBB) with 2,686 confirmed RA cases, and applied to RA unaffected 
TwinsUK participants. Association was then determined between RA PRS and composition of the gut 
microbiota in the TwinsUK cohort (n = 1650). Validation was performed in the SCREEN-RA cohort, comprised 
of RA unaffected first degree relatives of RA patients. First degree relatives of RA patients share on average 
50% of their genotype with their RA affected relative, and thus have higher RA genetic risk than the general 
population. In addition, participants were genotyped for SE RA risk alleles – the strongest genetic association 
with RA, and assessed for pre-RA status as defined by clinical RA parameters.9 The gut microbiota composition 
was examined in relation to SE genotype and pre-RA in the SCREEN-RA cohort (n=133; Figure 1).  
 
Favourable ethical opinion was granted by the formerly known St. Thomas’ Hospital Research Ethics 
Committee (REC). Following restructure and merging of REC, subsequent amendments were approved by the 
NRES Committee London - Westminster (TwinsUK, REC ref: EC04/015, 1 November 2011); use of microbiota 
samples was granted NRES Committee London - Westminster (The Flora Twin Study, REC ref: 12/LO/0227, 1 
November 2011). 
 
Figure 1.  Schematic representation of the study design. The TwinsUK cohort is led by King’s College London 
located at St Thomas Hospital NHS Foundation Trust, and is comprised of adult twins resident in the UK. 
SCREEN-RA is a Swiss multi-centre cohort comprised of first-degree relatives of RA patients. 
 
  
 
 
5 
Participants 
Participants included in the study were members of the TwinsUK cohort, the largest UK registry of adult twins,8 
with the exception that participants reporting a diagnosis of RA (identified by the following multiple choice 
questionnaire: “Has a doctor ever told you that you have/had any of the following conditions? Rheumatoid 
Arthritis” ),  as well as their unaffected co-twin were excluded. The TwinsUK registry is demographically well 
suited to the study of RA -  most participants are female and of more advanced age, as such study specific 
inclusion criteria were not necessary. TwinsUK participants comprised 93% females, having a median age of 63 
(Table 1).   
 
To validate the results from TwinsUK, an analysis of RA genetic predisposition and microbiota association was 
performed in participants of SCREEN-RA, a Swiss multicentre cohort of first-degree relatives of RA patients.9 
Within SCREEN-RA participants (n=133), the subset of pre-clinical RA cases (n = 83) were identified based on 
the European League Against Rheumatism terminology for pre-clinical phases of RA,9  and matched with 50 
controls who were also first degree relatives of RA patients. Briefly, pre-clinical RA was defined on the basis of 
serum positivity for anti-citrullinated protein antibody (ACPA) or rheumatoid factor and/or symptoms and signs 
associated with possible RA with or without undifferentiated arthritis.9 Patients with a diagnosis of RA were 
excluded from the analysis and  all participants had been examined by a trained nurse. Of SCREEN-RA 
participants, 84% were female and the median age was 57 (Table 1). 
 
Participants provided written informed consent. 
 
 Age 
median 
(IQR) 
Female 
Sex 
n(%) 
BMI 
median 
(IQR) 
ACPA 
+ve 
n(%) 
RF 
+ve 
n(%) 
SE    
+ve 
n(%) 
ACPA 
& RF 
+ve   
n(%) 
Current 
Smoker     
n(%) 
Anti-
biotics 
prior 
month 
n(%) 
Ethnicity Swollen 
joints 
median 
(IQR) 
Tender 
joints 
median 
(IQR) 
T
w
in
sU
K
 
RA 
unaffected  
n = 1650 
63     
(56-69) 
1535 
(93) 
25     
(23-29) 
 9*        
(2) 
 35*    
(7) 
.. 
1      
(0) 
567     
(34) 
66           
(4) 
Caucasian; 
Northern 
European 
.. NA 
S
C
R
E
E
E
N
-R
A
 
Pre-RA 
n=83 
58     
(50-66) 
74   
(89) 
24   
(22-27) 
38      
(46) 
28 
(34) 
42     
(53) 
6      
(5) 
16      
(13) 
.. 
Caucasian; 
Northern 
European 
1          
(0-3) 
1           
(0-2) 
FDR 
controls   
n=50 
55     
(47-62) 
39   
(78) 
24   
(22-27) 
0          
(0) 
0    
(0) 
32     
(65) 
0      
(0) 
11        
(6) 
.. 
Caucasian; 
Northern 
European 
0          
(0-1) 
0           
(0-1) 
Table 1. Summary of participant demographics. Anti citrullinated protein antibody(ACPA) positivity is defined 
as >5ul/ml. Rheumatoid factor (RF) positivity is defined as >15ul/ml. 
*Serum samples analysed for 500 TwinsUK participants including those with highest PRS. 
 
Genotyping: TwinsUKcohort 
Blood samples from TwinsUK participants obtained at clinical visit were used to determine genotype using the 
Illumina HumanHap300 BeadChip and the Illumina HumanHap610 QuadChip. Non-genotyped variants were 
imputed using 1000 Genomes and Haplotype Reference Consortium (HRC) reference panels.8 
 
Polygenic Risk Score for RA in TwinsUK 
The polygenic risk score (PRS) assigns an individual a single numerical value for risk of disease conferred by 
genetic factors.10 The NCBI database of GWAS summary statistics for RA was used to identify 233 published 
single nucleotide polymorphisms (SNPs) associated with RA at genome-wide significance (P = 5e-8) of which 
117 had been replicated across studies (Supplementary Table 3).11 A study inclusion criterion of European 
ancestry ensured ethnic concordance with TwinsUK.8,12 The PRS was tested for RA predictive value in 6,776 
participants from UK Biobank including 2,686 RA cases and 4,090 unselected controls with chronologically 
closest participant identification numbers. Diagnosis of RA in UK Biobank participants had been determined 
using hospital episode statistics (HES) data supplied by NHS Digital. All identified RA cases were included. No 
exclusion criteria were necessary: UKBB is ethnically representative of TwinsUK. Logistic regression of RA 
cases and unselected controls against PRS, adjusting for age, sex and smoking history, was applied. 
Standardised coefficients are reported. 
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Risk allele dosage of SNPs present within TwinsUK was extracted using Plink 1·9. Of the SNPs identified in 
the literature 227 were available in TwinsUK. Pruning was applied to account for linkage disequilibrium 13 
Missing allele dosages were imputed and replaced with the mean value across the respective SNPs. The risk 
allele dosage was multiplied by the SNP-RA association effect size, to produce a weighted PRS.10  
 
Microbiota profiling: TwinsUK 
Microbiota composition of gut (stool, n=1650) samples was assessed using the 16S rRNA marker gene, with 
sequencing of the V4 variable region using barcoded primers (F515/R806). Samples were processed as 
previously described.7 Briefly, faecal samples were collected during clinical visits or were posted in sealed ice 
packs and frozen on arrival at the lab at -80 C. Stool samples were sent as 35 batches on dry ice to Cornell 
University, where DNA was extracted and sequenced on an Illumina MiSeq platform.7  
 
16S sequences were demultiplexed in QIIME.  Amplicon sequence variants (ASVs) were generated using the 
DADA2 package in R.14 Sequences were trimmed, error estimated within the forward and reverse reads for each 
sample, and the ASV algorithm applied to infer the original biological sequence. Forward and reverse reads 
were joined. Chimeras were removed and the total dataset merged, followed by taxonomic assignment with 
SILVA1.3.2.15 Samples having a sequencing depth of less than 10,000 reads were excluded. A phylogenetic tree 
was generated using the Phangorn R package. Alpha diversity was calculated on untrimmed ASV tables using 
four measures: Shannon index, Simpson index, observed ASVs and Faith’s phylogenetic diversity. For the 
taxonomic analysis, ASVs were grouped according to taxon annotation. Taxonomic assignment using the 
SILVA database allows for a higher level of differentiation as in some instances it is possible to annotate  the 
genus of ASVs according to prediction of species group.18 These annotations were preserved as they provide 
more information regarding taxon assignment than genus annotation alone. In this way, Prevotella annotated 
ASVs may be accurately further differentiated using 16S data, which has been a methodological challenge 
previously. 
 
 
Statistical analysis: association of the gut microbiota alpha diversity with RA genetic risk  
Linear mixed-effects models were used to determine association between RA PRS and alpha diversity, using 
alpha diversity as a response variable to the RA PRS as a continuous variable. Modelling was performed using 
the lme4 package in R,16 with fixed effect covariates age, BMI and sequencing depth and technical covariates as 
random effects. Standardised coefficients were reported.  
 
 
Statistical analysis: taxonomic association of the gut microbiota with RA genetic risk 
Differential abundance of ASVs  present in more than 5% of samples, grouped by ASV taxon annotation, 
against the RA PRS as a continuous variable was assessed using the DESeq2 R package,17 using fixed-effects 
covariates as above. To account for multiple testing, the false discover rate (FDR) calculation was applied to all 
p values to generate q values, with a significance threshold of 0.05 determined a-priori.  
 
 
Phylogenetic and community relationship within the Prevotellaceae Family 
To investigate further the Prevotella spp. associations identified, the phylogenetic and community relationships 
between Prevotella_7 and Prevotella_9 were explored. For these methods, it was not appropriate to group ASVs 
by taxon annotation - ASVs were considered as singular units. 
 
In order to examine the microbial ecological community relationships, ASVs were grouped into compositional 
clusters, or balances. Briefly, ASVs present in at least 10 percent of individuals were correlated and transformed 
as implemented in Morton et al.19 This creates clades in which interacting species are closer neighbours in a 
clade than loosely related ones.  
 
To examine the phylogenetic relationship, the phylogenetic tree was subsetted to Prevotellaceae and visualised 
using the Phyloseq R package.20 
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Shared Epitope Genotyping: SCREEN- RA cohort 
Blood was taken from patients and controls. DNA was extracted using a modification of the salt-out technique 
(Nucleon TM, Scotlab, UK). HLA-DRB1 Shared Epitope polymorphism was determined by reverse polymerase 
chain reaction - sequence-specific oligonucleotide primers hybridization and by polymerase chain reaction - 
sequence-specific primers using commercial reagents validated at the  Swiss National Reference Laboratory for 
Histocompatibility. Within the DRB1*04 genotype the method discriminates all major subtypes in different 
allele groups. HLA-DR1, DR4 and DR14 alleles that are negative for the SE70-74 motif are also discriminated. 
In a second step, the SE-positive typing ambiguities were analyzed by PCR-SSP in order to determine the final 
4-digit typing result.  
 
Microbiota Profiling: SCREEN-RA cohort  
Gut microbiota 16S rRNA data was collected as previously described.9 Briefly, the DNA Genotek 
OMNIgene∙Gut Stool Microbiome Kit was used to collect, store and ship the stool samples. After sample 
processing and DNA extraction, the V4 region of the 16S rRNA gene was amplified using barcoded primers 
(F515/R806), and sequenced on an Illumina MiSeq, with ASVs generated as per the TwinsUK cohort to ensure 
compatibility. 
 
Statistical Analysis: SCREEN-RA cohort 
Differential abundance of taxa in the gut microbiota in association with pre-clinical RA and SE positivity was 
assessed against all genus present in greater than 5% of samples using the DESeq2 R package.17 Biological 
covariates were not required to adjust for as these factors were not statistically different between the case and 
control groups (Supplementary Table 1). This was a repeat of the published study by Alpizaar-Rodriguez et 
al., with the advancement that ASVs and DESeq2 methods were used.9 
 
Role of the Funding Source 
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing 
of the report. The following authors had access to the raw data: PW, AA, MF, RB, CS, FW. The corresponding 
authors had full access to all of the data and the final responsibility to submit for publication. 
 
 
 
Results 
 
TwinsUK participants comprised 1650 RA-unaffected adult twin volunteers the majority of whom were female. 
Table 1 summarises the characteristics of the sample. 
 
The polygenic risk score was normally distributed in the TwinsUK sample with RA cases and twin siblings 
excluded (Shapiro-Wilk normality test P = 0·24). Logistic regression of the PRS in 6,776 UK biobank 
participants, of which 2,686 had a HES diagnosis of RA, confirmed that the score is predictive of RA (odds 
ratio per standard deviation = 1·34; P = 4·17e-8).  
 
High PRS individuals in TwinsUK did not demonstrate RA seropositivity:  only 9/500 individuals in the 
TwinsUK sample having serum available were positive for anti-citrullinated protein antibody (ACPA; defined 
as >5u/mL) (Table 1), and they were distributed similarly across genetic risk groups, by PRS quartile (high 
2:93; low 7:398). 
 
We determined whether genetic risk of RA is associated with alpha (within sample)  diversity. There was no 
detectable association between RA PRS and Shannon Index (P = 0·76), Simpson Index (P = 0·41), Observed 
ASVs  (P=0·6) or Faith’s phylogenetic diversity (P=0·65; Supplementary Table 2). Alpha diversity measures 
indicate microbial density or “richness” (Observed ASVs) and distribution, or “evenness” in which the 
distribution of more abundant versus less abundant taxa is assessed, or both of these factors (Shannon Index, 
Simpson Index). Faith’s phylogenetic diversity is based on the phylogenetic distance between taxa in a sample.  
The gut microbiota were taxonomically assessed for association with RA PRS following a non-targeted 
approach. Of all 172 microbial taxa which were present in the gut (stool) microbiota of more than 5% of 
participants, Prevotella_7 was the strongest taxon association with the RA PRS  (18-fold log base 2 higher 
differential abundance; q < 1e-7) (Figure 2). No additional Prevotella assocations with the RA PRS were 
demonstrated. 
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Figure 2. Differential abundance of the gut microbiota per unit increase in RA PRS in TwinsUK participants. 
Positive log-fold change of taxa indicates a positive association with the RA PRS. Prevotella_7 was the 
strongest association, and positively associated with RA PRS (q < 1e-7). Due to the scale and comparative 
difference in log-fold change in Prevotella, this taxon is excluded in B to allow visualisation of the 3 other 
associations. Other taxa associations within the gut microbiota were Ruminococcaceae_UCG-14 (q = 0·045), 
Rikenella (q = 0·018) and Shigella (q = 0·018). 
 
We sought to confirm our findings in gut microbiota from the SCREEN-RA cohort by analysing the association 
between the main genetic risk factor for RA -  HLA-DRB1 shared epitope (SE), and the gut microbiota. As the 
cohort comprises first-degree relatives of RA patients it has a higher genetic risk for RA than the general 
population. Participants had also been genotyped for SE risk alleles.  
 
Prevotella_9 was positively associated with pre-clinical RA (q = 0·021; Figure 3). Prevotella_7 was associated 
with HLA-DRB1 SE RA risk alleles in the SCREEN-RA cohort (n=133; q = 0·035); the association was 
stronger in a subgroup analysis in which the 44 participants with swollen joints were removed, in order to 
isolate genotype from RA pathophysiology (n=89; q = 1·1e-3), Figure 4. In the subgroup analysis of differential 
abundance against SE positivity in asymptomatic participants only, Prevotella_7 was the only remaining taxon 
association. This finding validates the TwinsUK Prevotella_7 association.  
 
Prevotella_7 and Prevotella_9 are groups of Prevotella ASVs, according to predicted species. Prevotella_9 is 
predicted Prevotella_copri, whereas Prevotella_7 is annotated to multiple Prevotella species, with low sequence 
divergence. The key implication is that Prevotella_9 and Prevotella_7 are distinct from one another, and 
Prevotella_9 is predicted to be Prevotella copri.15,16  
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Figure 4. Differential abundance of the gut microbiota in HLA-DRB1 shared epitope positive participants, 
compared to shared epitope negative controls in the SCREEN-RA cohort. In A all participants were analysed. 
Prevotella_7 showed the most substantial positive log fold change of 5 (q= 3·48e-2). Other genus associations 
were Veillonella (q = 3·48e-2), Streptococcus (q = 3·48e-2), Ruminococcaceaae UBA1819 (q = 3·48e-2) and 
Coprobacter (q = 2·03e-3). In B participants with RA associated symptoms – tender or swollen joints were 
excluded, here, Prevotella_7  solely remained positively associated with shared epitope positivity (q = 1·12e-3). 
 
 
 
 
 
Figure 3. Differential abundance of the gut microbiota in pre-clinical RA cases compared to uaffected 
controls in the SCREEN-RA cohort. Prevotella_9 was associated with pre-clinical RA (q = 0·021). There 
were 6 additional genus group associations: Lactobacillus (q = 2·6e-4), Butyrivibrio (q = 0·018), 
Ruminococcaceae_UCG-D08 (q = 0.018), Enterococcus (q =0·018), DTU089 (q = 0·042), and Veilllonella (q 
= 0·042). 
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As Prevotella spp. are the strongest taxon associations in our results and of particular interest in RA, we further 
investigated the phylogenetic and community relationships within Prevotellaceae. In particular, we were 
interested in the relationship between Prevotella_7 and Prevotella_9 as these were associated with genetic risk 
and pre-clinical RA, respectively. Cluster analysis demonstrated a community relationship between Prevotella 
spp. Prevotella_7 and Prevotella_9 were the only 2 species clusters within the Prevotellaceae family, and 
clustered together more frequently than any other group, suggesting an inter-dependent community relationship 
between these taxa (Figure 5A). Visualisation of the Prevotellaceae phylogenetic tree demonstrated that 
Prevotella_7 and Prevotella_9 are phylogenetically distinct from one another (Figure 5B). 
 
 
 
Figure 5.  A) Cluster tree showing an ecological community relationship between Prevotella ASVs within stool 
samples from TwinsUK participants. Taxa clades represent members of the same microbial ecological 
community. Prevotella_9 and Prevotella_7 are the only 2- taxon clusters present, and ASVs assigned to these 
taxa cluster in the same clade more frequently than any other others taxa. Clustering of Prevotella_7  and 
Prevotella_9  ASVs indicates that the abundance of these taxa are interdependent; a biological interdependence 
and environmental niche similarity is suggested. Incremental levels are shown, from individual ASVs joined as 
two-taxon clusters, to the full set of Prevotellaceae ASVs joined by the final head node. B) Phylogenetic tree for 
Prevotellaceae ASVs within TwinsUK participants. Prevotella_9 and Prevotella_7 are phylogenetically distinct 
from each other. 
 
 
Prevotella_7 may be implicated in RA pathogenesis, and may, indeed, be increased in RA patients (resilience 
hypothesis, described in Supplementary Methods). Conversely, given that the RA-unaffected TwinsUK 
participants are beyond the mean age of RA onset, yet having high genetic risk in some, these results may 
hypothetically reflect participants being resilient to the development of RA. Correspondingly, the genetic risk 
and microbiota associations demonstrated may potentially be microbial markers of RA resilience. In this 
instance, the ratio of Prevotella_7:Prevotella_9 (copri)  would be expected to be higher in unaffected twins.  
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The relative abundance of Prevotella spp. was calculated in 18 monozygotic female RA-discordant twin pairs 
excluded from our previous analysis, in whom RA diagnosis had been confirmed during clinical visit. A higher 
relative abundance of Prevotella_7 was demonstrated in the RA affected twins compared to control twins: 0.005 
and 0·001, respectively (Supplementary Figure 1). This finding neither supports nor rejects the hypothesis that 
Prevotella_7 is implicated in RA aetiology: In accordance with other studies of established RA,  abundance of 
Prevotella spp. was not significantly associated with RA. The proportion of Prevotella_7 (species prediction 
uncertain)  to Prevotella_9 (predicted Prevotella copri) was higher in the RA affected twins than the control 
twins: 0·4 and 0·01, respectively, suggesting that Prevotella_7 is not a marker of RA resilience. 
 
 
 
Discussion 
 
This study demonstrates a link between host genetic risk for RA and the gut microbiota in two large human 
cohorts. Gut microbiota associations have been demonstrated in the absence of clinically detectable disease in 
TwinsUK: participants with RA, along with their unaffected co-twins, were removed from the study. The 
strongest association between RA genetic risk and the gut microbiota was an increase in abundance of 
Prevotella_7 (q <1e-7). This finding was validated in the SCREEN-RA cohort in which Prevotella_7 was 
positively correlated with shared epitope positivity (q =1·1e-3). Prevotella_7 was demonstrated to share a 
biological interdependence with Prevotella_9 (predicted P.copri).  
 
There is considerable interest in Prevotella copri as a potential mediator of RA pathology, and it is a candidate 
keystone taxon enriched in the gut microbiota of newly diagnosed RA patients. Since this observation was 
made, the human immune response to this microbe has been of considerable interest. Antibodies to P.copri have 
been shown to associate with disease severity and innate- and Th1 and Th17 immune responses in RA21.  
Functional work has suggested a role for P.copri in Th17 cell differentiation.22 That P.copri  is associated with 
new-onset RA prior to treatment with DMARDS, 4 and is also associated with other inflammatory conditions,23 
has fuelled speculation that inflammation is a pre-requisite for P.copri proliferation within the gut, relative to 
other taxa.21,24 P.copri may have adapted to thrive in a pro-inflammatory environment, and may further promote 
the inflammatory milieu, thereby enhancing its own favoured environmental niche.24 In doing so, P.copri  is 
suggested to contribute to RA pathology. According to this model, a human–microbiota interspecies positive 
feedback loop is proposed. Another example of such a model is the hijacking of complement cascade by 
Porphyromonas gingivalis.25  
 
An increase in abundance of three other taxa – Ruminococaceae_UCG-14, Rikenella and Shigella - with RA 
PRS was also observed. Ruminococcaceae and Shigella have been shown previously to be in higher abundance 
in RA patients compared to controls.3,4 The evidence for a role of these taxa in RA is much weaker than for 
P.copri - with lower replication across studies, and no functional link reported to date. However, the association 
both with RA patients and with genetic risk for RA in a large, non-disease cohort is interesting, and merits 
further investigation. 
 
Whilst causality is not determinable from a cross sectional association study, our results provide robust evidence 
indicating that host genetic factors influence the abundance of Prevotella in the gut micobiota. Both TwinsUK 
and SCREEN RA cohorts were balanced for ACPA positivity in relation to RA genetic risk loci. A previous 
study of new onset RA patients and healthy participants reported an inverse association of HLA genotype with 
abundance of  Prevotella copri, in the opposite direction to that expected.5 This association may potentially 
relate to population differences or confounding factors which were not examined. The present study using ASVs 
in a very large sample without disease provides more substantial evidence for an association of genotype with 
the RA gut microbiota.  
 
The findings suggest that the microbiota are altered prior to disease and this is in accord with previous reports of 
Prevotella spp. in pre-RA9 and RA.5 Indeed, we find similar in the pre-clinical RA cases in first degree relatives 
of RA patients: in a recent study of the SCREEN-RA cohort an enrichment of Prevotellaceae in the gut 
microbiota in pre-RA was observed. In the study by Alpizaar-Rodriguez et al.9 no statistically significant 
Prevotellaceae genera were shown to drive the association. Therefore in the present study data were re-analysed 
using the more recent method of ASVs. ASVs offer an updated approach to traditional clustering based methods 
generating OTUs from 16S sequence. As opposed to grouping sequences based on a similarity threshold as for 
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OTUs, the error rate is used to infer the original biological sequence, and produce units of matched sequence. 
ASVs offer higher resolution, and have greater biological relevance therefore.26 The ASV analysis showed an 
FDR-adjusted significant Prevotella genus association with a species level group annotation indicating potential 
Prevotella copri. Our follow-up study of  pre-RA revealed a furthersix novel genus associations which had not 
been evident in the original OTUs– Lactobacillus, Enterococcus, Faecalibacterium, Ruminococcaceae 
UBA1819, Veilllonella and Butyrivibrio. Of the six associations, the first four have been reported associated 
with RA previously,4,27,28 and Ruminococcaceae was seen associated with RA PRS in TwinsUK. Butyrivibrio 
has not yet been associated with RA, but this is a physiologically interesting taxa associated with short chain 
fatty acid production and host metabolism. 
 
 
There are a number of limitations to the study. First, in the pre-RA follow-up analysis both cases and controls 
were first degree relatives of RA patients, with increased genetic risk compared to the general population. It is 
possible that the pre-clinical RA cases had higher genetic risk than the controls, but as full genotyping was not 
available, we were unable to confirm this. The TwinsUK cohort is predominantly female (Table 1). The 
SCREEN-RA cohort is slightly more balanced in terms of sex, however population prevalence of RA is much 
higher in females than males. As the age of onset of RA is 30-65,29  the TwinsUK participants who have a 
median age of 63 are less likely to develop disease than the SCREEN-RA participants. However, this is of 
benefit to the design of our study of genetically high risk yet unaffected individuals and helps us to understand 
microbiota differences in the absence of disease.  
 
This work highlights the value of using the newer methods of amplicon sequence variants – ASVs - which can 
detect taxonomic variation overlooked by OTU based methods. Further microbiota associations with RA are to 
be anticipated from improvements in sequencing and its interpretation. Annotation of ASVs with the SILVA 
database15,18 demonstrates differences at the species level which would be overlooked using other reference 
databases. Finally, modelling of the community relationship provides valuable insight into the underlying 
biology. Future studies should take advantage of these methods. 
 
Taken together, these results support the hypothesis that microbiota is altered in individuals with genetic 
predisposition to RA before the onset even of pre-clinical RA. The work sheds light on our understanding of 
microbiota in RA and addresses the cause vs consequence issue; – if microbial alteration precedes disease, the 
microbiota may lie on the causal pathway. However we cannot yet exclude the possibility that Prevotella spp. 
are bystanders.  Additionally, having RA genetic risk and Prevotella spp. is not sufficient for disease 
development, but rather may be one of several insults contributing to progression of RA pathology, in line with 
the favoured “two hit hypothesis” of RA pathogenesis.30 The identification of pre-clinical RA represents an 
important clinical target in early disease intervention and is currently the subject of multiple immune-
modulating clinical trials. Further, the genetic risk-microbiota associations identified here may be applicable to 
other diseases as there is crossover in genetic aetiology between RA and other autoimmune conditions. Finally, 
the microbiota may offer the opportunity for modulation of pre-disease pathways alone or in combination with 
immune-modulating drugs. 
 
 
 
Conclusions 
 
Gut microbiota abundance is associated with RA risk genotype even in the absence of disease. Genotype may 
mediate key taxonomic associations of the gut microbiota with RA, particularly Prevotella spp.4,5,21,22 
suggesting that these species play a role very early in development of RA. 
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